Feature Channels:

Neuro

Add to Favorites Subscribe Share
Newswise: Helping the world understand, detect and treat a devasting genetic disorder

Helping the world understand, detect and treat a devasting genetic disorder

UC Davis MIND Institute

Fragile X syndrome is a debilitating genetic neurodevelopmental disorder that affects people worldwide, but many doctors don’t know anything about it, let alone have the resources to properly diagnose or treat it.

Channels: All Journal News, Autism, Children's Health, Family and Parenting, Healthcare, Neuro, Genetics, Europe News,

Released:
23-Jan-2020 1:55 PM EST
Embargo will expire:
24-Jan-2020 2:00 PM EST
Released to reporters:
23-Jan-2020 1:25 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2020 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results

Healing and Hope: Treating Fragile X in Serbia

UC Davis MIND Institute

Doctors and scientists — experts in the rare and severely disabling fragile X syndrome — had arrived from the United States, including six from the UC Davis MIND Institute. They came to offer the families useful information and maybe open doors to desperately needed help in a region of the world that, until fairly recently, hardly recognized fragile X syndrome, let alone knew how to diagnose or treat it.

Channels: All Journal News, Autism, Children's Health, Family and Parenting, Healthcare, Neuro,

Released:
23-Jan-2020 1:20 PM EST
Research Results
Embargo will expire:
24-Jan-2020 12:05 AM EST
Released to reporters:
23-Jan-2020 12:55 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2020 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Feature
Newswise: UW research expands bilingual language program for babies

UW research expands bilingual language program for babies

University of Washington

A study by the University of Washington's Institute for Learning & Brain Sciences (I-LABS) shows that a bilingual language program for babies can reach more families, and instructors, through online training for teachers.

Channels: Cognition and Learning, Education, Neuro, Family and Parenting, In the Home, Speech & Language, All Journal News,

Released:
23-Jan-2020 11:55 AM EST
Research Results

Education

Embargo will expire:
28-Jan-2020 3:05 AM EST
Released to reporters:
23-Jan-2020 11:50 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 28-Jan-2020 3:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
  • Embargo expired:
    23-Jan-2020 11:00 AM EST

Largest Autism Sequencing Study to Date Identifies 102 Genes Associated With the Condition

Mount Sinai Health System

In the largest genetic sequencing study of autism spectrum disorder (ASD) to date, researchers have identified 102 genes associated with risk for autism. The study also shows significant progress towards teasing apart the genes associated with ASD from those associated with intellectual disability and developmental delay, conditions which often overlap.

Channels: All Journal News, Autism, Children's Health, Neuro, Cell (journal),

Released:
16-Jan-2020 3:00 PM EST
Research Results
Newswise: Study Finds a Drug-Like Compound That May Prevent Parkinson’s Disease Progression

Study Finds a Drug-Like Compound That May Prevent Parkinson’s Disease Progression

Rutgers Robert Wood Johnson Medical School

A collaboration between scientists at Rutgers University and The Scripps Research Institute led to the discovery of a small molecule that may slow down or stop the progression of Parkinson’s disease.

Channels: All Journal News, Chemistry, Neuro, Parkinson’s Disease, Pharmaceuticals, Technology, National Institutes of Health (NIH),

Released:
23-Jan-2020 10:55 AM EST
Research Results
UNM_ComprehensiveCancerCenter_Vertical_CMYK.jpg

A Menu of Brain Cancer Treatments

University of New Mexico Comprehensive Cancer Center

Sara Piccirillo, PhD, is passionate about finding a way to beat glioblastoma, the most aggressive type of brain cancer. Her research focuses on a feature of glioblastoma tumors that appears to be the source of their strength: the extreme differences among their tumor cells.

Channels: Cancer, Healthcare, Neuro, Pharmaceuticals,

Released:
23-Jan-2020 8:05 AM EST
Research Results
Signature-Vertical.png

Study Uncovers Unexpected Connection Between Gliomas, Neurodegenerative Diseases

Michigan Medicine - University of Michigan

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.

Channels: Alzheimer's and Dementia, Cancer, Healthcare, Neuro, National Institutes of Health (NIH), All Journal News,

Released:
22-Jan-2020 7:20 PM EST
Announcement


38.18571